Febuxostat and Systemic candida - a phase IV clinical study of FDA data

Summary:

Systemic candida is reported only by a few people who take Febuxostat.

The phase IV clinical study analyzes which people take Febuxostat and have Systemic candida. It is created by eHealthMe based on reports of 5,968 people who have side effects while taking Febuxostat from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 26, 2022

5,968 people reported to have side effects when taking Febuxostat.
Among them, 4 people (0.07%) have Systemic candida.

What is Febuxostat?

Febuxostat has active ingredients of febuxostat. eHealthMe is studying from 6,000 Febuxostat users for its effectiveness, alternative drugs and more.

What is Systemic candida?

Systemic candida (whole body fungal infection) is found to be associated with 723 drugs and 376 conditions by eHealthMe.

Number of Febuxostat and Systemic candida reports submitted per year:

Could Febuxostat cause Systemic candida?

Gender of people who have Systemic candida when taking Febuxostat *:

female: 75 %
male: 25 %

Age of people who have Systemic candida when taking Febuxostat *:

Common drugs people take besides Febuxostat *:

Amlodipine: 2 people, 50.00%
Ursodiol: 1 person, 25.00%
Tacrolimus: 1 person, 25.00%
Sulfamethoxazole And Trimethoprim: 1 person, 25.00%
Sennosides: 1 person, 25.00%
Prednisolone: 1 person, 25.00%
Lansoprazole: 1 person, 25.00%
Carvedilol: 1 person, 25.00%
Calcitriol: 1 person, 25.00%
Aspirin: 1 person, 25.00%

Common side effects people have besides Systemic candida *:

Sepsis (a severe blood infection that can lead to organ failure and death): 2 people, 50.00%
Hypocalcaemia (levels of calcium in blood serum are abnormally low): 2 people, 50.00%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 2 people, 50.00%
Cardiac Failure: 2 people, 50.00%
Renal Impairment (severely reduced kidney function): 1 person, 25.00%
Pleural Effusion (water on the lungs): 1 person, 25.00%
Pancreatitis Acute (sudden inflammation of pancreas): 1 person, 25.00%
Hepatitis C: 1 person, 25.00%
Candida Pneumonia (infection of lung by candida): 1 person, 25.00%

Common conditions people have *:

Osteoporosis (bones weak and more likely to break): 3 people, 75.00%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 25.00%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 1 person, 25.00%
High Blood Pressure: 1 person, 25.00%
Cerebral Infarction (less blood supply to brain resulting tissue damage): 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Febuxostat and have Systemic candida?

Check whether Systemic candida is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Systemic candida and when was it recovered:

Systemic candida in Febuxostat

Expand to all the drugs that have ingredients of febuxostat:

Systemic candida and drugs with ingredients of febuxostat

Alternative drugs to, pros and cons of Febuxostat:

Febuxostat (6,000 reports)

Common Febuxostat side effects:

Rashes (redness): 564 reports
Headache (pain in head): 476 reports
Drug ineffective: 418 reports
Diarrhea: 380 reports

Browse all side effects of Febuxostat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Systemic candida treatments and more:

Systemic candida (3,219 reports)

COVID vaccines that are related to Systemic candida:

Common drugs associated with Systemic candida:

All the drugs that are associated with Systemic candida:

Systemic candida (723 drugs)

All the conditions that are associated with Systemic candida:

Systemic candida (376 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on febuxostat (the active ingredients of Febuxostat) and Febuxostat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.